Tobacco Plant Transformed into Plague Vaccine Factory















Share on Tumblr

tobacco, plague, vaccine

Image:

  • What a Plant Knows

    How does a Venus flytrap know when to snap shut? Can it actually feel an insect’s tiny, spindly legs? And how do cherry blossoms know when to bloom? Can they...

    Read More »

Tobacco mosaic virus (TMV) is one of the oldest known diseases of the plant world. Plague--known as the "black death" in medieval Europe--is one of the oldest diseases afflicting humans, and has become a focus of concern in recent years because of its potential use as a bioweapon. Now scientists have transformed TMV to infect host plants and produce immunizing proteins rather than debilitating leaf shrivel, turning greenhouse tobacco into a biofactory for plague vaccine.

Biotechnology specialists Charles Arntzen and his colleagues at Arizona State University used a process developed in Germany to effect the change. First, they injected the tobacco plants with TMV, genetically modified to produce one of three previously proven plague antigens: proteins known as F1, V and a fusion of the two. The three varieties of modified viruses quickly infiltrated the plants and replicated, but instead of producing infection, each viral cell started producing its assigned type of antigen. Within 10 days, the researchers had a full crop of tobacco leaves filled with vaccine. "Every time it replicates, it makes the proteins that we are interested in getting produced," Arntzen says.

Arntzen and colleagues then ground up the leaves--garnering roughly two milligrams of antigen for every gram of leaf--and purified the resulting vaccine with acids. Fellow researchers at the U.S. Army Medical Research Institute of Infectious Disease in Maryland then vaccinated groups of eight female guinea pigs with the different varieties of antigens before exposing them to Yersinia pestis--the bacteria responsible for airborne plague, the most potentially deadly form. Within six days, whereas all guinea pigs that had not been vaccinated were dead, nearly 60 percent of the vaccinated guinea pigs survived, and even those that died survived for longer than six days. The V antigen proved most effective, saving 75 percent of the inoculated guinea pigs.

Human testing remains to be done. But if the vaccine passes that test, it could provide an effective deterrent to emerging strains that have shown resistance to the antibiotics that have kept the deadly disease at bay in recent history. The findings are being published online this week by the Proceedings of the National Academy of Sciences.



1 Comments

Add Comment
View
  1. 1. bertwindon 02:32 PM 1/6/10

    Happy New Year !
    That is totaly amazing.
    So as well as eating TNT, tobbacco can do this (with a little guidance from above). "It is an ill wind Indeed, which blows no good at all", but this is the first time I have seen this observation actually made use of ? !
    Oh of course ! fight Plague with -- er - tobacco ? ( and a virus, of course). Silly no-one thought of it sooner.
    Bizarre !

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Email this Article

Tobacco Plant Transformed into Plague Vaccine Factory

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X